471 related articles for article (PubMed ID: 10841283)
1. Antibody production by molecular farming in plants.
Fischer R; Hoffmann K; Schillberg S; Emans N
J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
[TBL] [Abstract][Full Text] [Related]
2. Molecular farming of recombinant antibodies in plants.
Fischer R; Liao YC; Hoffmann K; Schillberg S; Emans N
Biol Chem; 1999; 380(7-8):825-39. PubMed ID: 10494831
[TBL] [Abstract][Full Text] [Related]
3. Seed-based expression systems for plant molecular farming.
Boothe J; Nykiforuk C; Shen Y; Zaplachinski S; Szarka S; Kuhlman P; Murray E; Morck D; Moloney MM
Plant Biotechnol J; 2010 Jun; 8(5):588-606. PubMed ID: 20500681
[TBL] [Abstract][Full Text] [Related]
4. The sweet potato ADP-glucose pyrophosphorylase gene (ibAGP1) promoter confers high-level expression of the GUS reporter gene in the potato tuber.
Kim TW; Goo YM; Lee CH; Lee BH; Bae JM; Lee SW
C R Biol; 2009 Oct; 332(10):876-85. PubMed ID: 19819408
[TBL] [Abstract][Full Text] [Related]
5. Plant biopharming of monoclonal antibodies.
Ko K; Koprowski H
Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
[TBL] [Abstract][Full Text] [Related]
6. Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides.
Scheller J; Leps M; Conrad U
Plant Biotechnol J; 2006 Mar; 4(2):243-9. PubMed ID: 17177800
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
[TBL] [Abstract][Full Text] [Related]
8. Plants as bioreactors: a comparative study suggests that Medicago truncatula is a promising production system.
Abranches R; Marcel S; Arcalis E; Altmann F; Fevereiro P; Stoger E
J Biotechnol; 2005 Oct; 120(1):121-34. PubMed ID: 16026877
[TBL] [Abstract][Full Text] [Related]
9. Haploid technology allows for the efficient and rapid generation of homozygous antibody-accumulating transgenic tobacco plants.
Floss DM; Kumlehn J; Conrad U; Saalbach I
Plant Biotechnol J; 2009 Sep; 7(7):593-601. PubMed ID: 19627562
[TBL] [Abstract][Full Text] [Related]
10. Semicontinuous bioreactor production of a recombinant human therapeutic protein using a chemically inducible viral amplicon expression system in transgenic plant cell suspension cultures.
Huang TK; Plesha MA; McDonald KA
Biotechnol Bioeng; 2010 Jun; 106(3):408-21. PubMed ID: 20198659
[TBL] [Abstract][Full Text] [Related]
11. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome.
Daniell H
Biotechnol J; 2006 Oct; 1(10):1071-9. PubMed ID: 17004305
[TBL] [Abstract][Full Text] [Related]
12. A simple and effective system for foreign gene expression in plants via root absorption of agrobacterial suspension.
Yang L; Wang H; Liu J; Li L; Fan Y; Wang X; Song Y; Sun S; Wang L; Zhu X; Wang X
J Biotechnol; 2008 Apr; 134(3-4):320-4. PubMed ID: 18353478
[TBL] [Abstract][Full Text] [Related]
13. Transient expression of fluorescent fusion proteins in protoplasts of suspension cultured cells.
Miao Y; Jiang L
Nat Protoc; 2007; 2(10):2348-53. PubMed ID: 17947977
[TBL] [Abstract][Full Text] [Related]
14. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants.
Fischer R; Drossard J; Commandeur U; Schillberg S; Emans N
Biotechnol Appl Biochem; 1999 Oct; 30(2):101-8. PubMed ID: 10512787
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production.
Obregon P; Chargelegue D; Drake PM; Prada A; Nuttall J; Frigerio L; Ma JK
Plant Biotechnol J; 2006 Mar; 4(2):195-207. PubMed ID: 17177796
[TBL] [Abstract][Full Text] [Related]
16. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants.
Vézina LP; Faye L; Lerouge P; D'Aoust MA; Marquet-Blouin E; Burel C; Lavoie PO; Bardor M; Gomord V
Plant Biotechnol J; 2009 Jun; 7(5):442-55. PubMed ID: 19422604
[TBL] [Abstract][Full Text] [Related]
17. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
[TBL] [Abstract][Full Text] [Related]
18. Manufacturing antibodies in the plant cell.
Orzáez D; Granell A; Blázquez MA
Biotechnol J; 2009 Dec; 4(12):1712-24. PubMed ID: 20014227
[TBL] [Abstract][Full Text] [Related]
19. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody.
Floss DM; Sack M; Arcalis E; Stadlmann J; Quendler H; Rademacher T; Stoger E; Scheller J; Fischer R; Conrad U
Plant Biotechnol J; 2009 Dec; 7(9):899-913. PubMed ID: 19843249
[TBL] [Abstract][Full Text] [Related]
20. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
Sivakumar G
Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
